Transcription of 2016 ACC/AHA/HFSA Focused Update on New …
{{id}} {{{paragraph}}}
Guidelines2016 ACC/AHA/HFSA Focused Update on New PharmacologicalTherapy for Heart Failure: An Update of the 2013 ACCF/AHAG uideline for the Management of Heart FailureA Report of the American College of Cardiology/American HeartAssociation Task Force on Clinical Practice Guidelines and the HeartFailure Society of AmericaDeveloped in Collaboration With the American College of Chest Physicians and International Societyfor Heart and Lung TransplantationWRITING COMMITTEE MEMBERS*Clyde W. Yancy, MD, MSc, MACC, FAHA, FHFSA, Chair,Mariell Jessup, MD, FACC, FAHA, FESC, Vice Chair,Biykem Bozkurt, MD, PhD, FACC, FAHA,*, Javed Butler, MD, MBA, MPH, FACC, FAHA,*, Donald E. CaseyJr, MD, MPH, MBA, FACC, Monica M. Colvin, MD, FAHA, Mark H. Drazner, MD, MSc, FACC, FAHA, Gerasimos Filippatos, MD, FESC,*Gregg C. Fonarow, MD, FACC, FAHA, FHFSA,*, Michael M. Givertz, MD, FACC, FHFSA,*, Steven M. Hollenberg, MD, FACC,#JoAnn Lindenfeld, MD, FACC, FAHA, FHFSA,*, Frederick A.
the International Society for Heart and Lung Transplantation. The statements issued by the European Society of Cardiology writing committee went through a similarly rigorous
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Pharmacy and Therapeutics Committee-approved, Pharmacy and Therapeutics Committee-approved Therapeutic Interchanges, Health System Marquette Pharmacy and Therapeutics, Health System – Marquette Pharmacy and Therapeutics Committee, COMMITTEE, AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT SUBJECT, American College of Rheumatology, FOR PREPARATION OF THE GUIDELINES, Chapter 45 Hospital pharmacy management, Medication Guide, Florida Blue